Related Experiment Video
Updated: Feb 14, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Diagnostic Performance of Quantitative Lung Perfusion SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension: A
Yu-Sheng Liu1, Yi-Ching Lin1,2,3, Shih-Chuan Tsai1
1Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung 407, Taiwan.
Abstract:
Background: Lung perfusion SPECT/CT is central to the diagnostic evaluation of chronic thromboembolic pulmonary hypertension (CTEPH), yet current assessments remain qualitative. This pilot study aimed to explore a standardized quantitative method for lung perfusion SPECT/CT to differentiate CTEPH from non-CTEPH patients. Methods: We retrospectively analyzed lung perfusion SPECT/CT studies obtained over a three-year period in patients assessed for suspected CTEPH. Perfusion counts were divided into ten equal intervals from zero to the maximum perfusion counts, and each decile was used as a threshold to define perfusion defects. Perfusion defect fraction was quantified, and group differences, diagnostic performance, and correlations with mean pulmonary arterial pressure (mPAP) were evaluated. Results: CTEPH patients showed significantly higher perfusion defect fraction than non-CTEPH controls. The 10% threshold demonstrated the best diagnostic performance, with an optimal cutoff of 20.6%, yielding a sensitivity of 75% and specificity of 100% for identifying CTEPH. Patients with distal-type disease or small, localized perfusion defects exhibited perfusion defect fraction overlapping with controls. Perfusion defect fraction correlated significantly and positively with mPAP. Conclusions: In this pilot study, quantitative analysis of lung perfusion SPECT/CT demonstrated feasibility as a complementary method to visual interpretation. While promising, these findings are preliminary and require validation in larger populations to establish their clinical utility for CTEPH diagnosis.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
05:56Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis
Published on: August 9, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...